Professor Steve Webb
MBBS, MPH, PhD, FRACP, FCICM, FAHMS
Dr Steve Webb is a Senior Staff Specialist in Intensive Care Medicine at Royal Perth Hospital and a Professor of Critical Care Research in the School of Public Health and Preventive Medicine at Monash University. He also holds adjunct Professorial appointments at the University of Western Australia and the George Institute for Global Health.
Dr Webb is a trialist who designs and conducts clinical trials that provide definitive guidance on optimal management for patients with various forms of critical illness. He is a recipient of more than $80M in research funding and has published more than 140 original journal articles including manuscripts in the NEJM (4), JAMA (1), Lancet (2), and BMJ (1).
He is a past-Chair of the ANZICS Clinical Trials Group. He is the Vice-Chair of the International Forum of Acute Care Trialists and a member of the Executive of the International Severe Acute Respiratory Illness Consortium. He is a founding Director of the Australian Clinical Trials Alliance, a foundation Fellow and a member of Council of the Australian Academy of Health and Medical Sciences, and a member of the NHMRC Health Translation Advisory Committee.
His clinical research interests include pandemic preparedness, pneumonia, the long-term consequences of and recovery after critical illness, resuscitation and treatment of patients with septic shock, management of traumatic brain injury, pathogenesis of septic shock, antimicrobial therapy, acute kidney injury, sedation and prevention of delirium, and choice of intravenous fluids in critically ill patients. He is a lead investigator of SPRINT-SARI (Short Period Incidence Study of Severe Acute Respiratory Infection) and REMAP-CAP (Randomised, Embedded, Multifactorial, Adaptive, Platform Trial of Community Acquired Pneumonia) He has particular interest in novel and more efficient trial methods including Platform Trials using Bayesian statistical methods and cluster-crossover trials as well as the interface between clinical trials and healthcare policy.